Official Journal of EORTC, ESO, EACR, FECS and EUSOMA
Editor-in-Chief (EJC):
John Smyth
See editorial
board for all editors information
The European Journal of Cancer (including EJC Supplements), is an international
comprehensive oncology journal that publishes original research, editorial comments, review articles, and news on experimental oncology,
clinical oncology ... click here for full Aims & Scope
Official Journal of EORTC, ESO, EACR, FECS and EUSOMA
Editor-in-Chief (EJC):
John Smyth
See editorial
board for all editors information
The European Journal of Cancer (including EJC Supplements), is an international
comprehensive oncology journal that publishes original research, editorial comments, review articles, and news on experimental oncology,
clinical oncology (medical, pediatric, radiation, surgical), and on cancer epidemiology and prevention.
Official Journal of the European
Organisation for Research and Treatment of Cancer (EORTC), the European School of Oncology (ESO), the European Association for Cancer
Research (EACR), the Federation of European Cancer Societies (FECS) and the European Society of Mastology (EUSOMA).
Supplements to the European Journal of Cancer are published under the title EJC Supplements (ISSN 1359-6349). All subscribers to
European Journal of Cancer automatically receive this publication.
A Journal Related to Head & Neck Oncology & Pathology
Oral Oncology now accepts online-only submissions.
Visit Oral
Oncology EXTRA, the new online only companion journal to Oral Oncology.
Oral Oncology is an international interdisciplinary
journal which draws together for the first time issues relating to the aetiopathogenesis, epidemiology, prevention and management of
oral and perioral tumours and of oral disease in patients with malignancies. Papers are invited on the following aspects of cancers arising
in the lip, tongue, mouth, salivary glands, pharynx, and the related bones, soft tissues, and lymph glands. (1) Natural history of oral
cancer and pre cancer, basic pathology, mestastatic mechanisms. (2) Cellular and molecular markers for diagnosis and prognosis, oncogenes,
viruses, growth factors, and adhesion molecules. (3) Epidemiology, risk factors, prevention, screening, and intervention. (4) Advances
in imaging and other functional diagnostic modalities. (5) Surgical advances, lasers, photo dynamic therapy, cyro surgery, micro vascular
surgery. (6) Multimodality treatment, radiotherapy, chemotherapy, immunotherapy, gene therapy. (7) Advances in reconstruction and rehabilitation,
grafts, alloplasty, bone and connective tissue biology, osteoradionecrosis. (8) Teamwork in cancer care, quality of life, nursing, speech
and swallowing therapy, nutrition, counselling, pain control, terminal care. (9) Oral effects of tumours at both local and distant sites
and their treatment. Research data may be submitted as a paper, short communication or letter. The journal will consider negative
results from well designed studies, which may be published as short communications or letters. Letters may be published as short communications.
Letters that comment on an article previously published in the same journal or that express a viewpoint about oncology are also invited.
All published papers and short communications, and selected letters containing research data are peer reviewed.
Home | Elsevier Sites | Privacy Policy | Terms and Conditions | Feedback | Site Map | A Reed Elsevier Company